Published April 26, 2018
| Version v1
Patent
Open
C-CBL MUTATIONS AND USES THEREOF
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
The present invention relates generally to the fields of molecular biology and growth factor regulation. The invention concerns methods and compositions useful for diagnosing and treating human lung cancer associated with mutated c-CBL.
Files
US20180112270.pdf
Files
(3.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:c568986b855ee6c378f86b8d11b5e4b3
|
3.3 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201615077409 A
- Patent number
- US 2018/0112270 A1
- Other
- oai:uchicago.tind.io:9227
Dates
- Patent filed
-
2016-03-22